These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20412181)

  • 1. Alternatives for malaria prophylaxis during the first trimester of pregnancy: our personal view.
    Hellgren U; Rombo L
    J Travel Med; 2010; 17(2):130-2. PubMed ID: 20412181
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic use of antimalarials during pregnancy.
    Irvine MH; Einarson A; Bozzo P
    Can Fam Physician; 2011 Nov; 57(11):1279-81. PubMed ID: 22084457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of atovaquone-proguanil during pregnancy.
    Mayer RC; Tan KR; Gutman JR
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30544231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of malaria].
    Botella de Maglia J; Espacio Casanovas A
    Rev Clin Esp; 1999 Aug; 199(8):549-50. PubMed ID: 10522443
    [No Abstract]   [Full Text] [Related]  

  • 5. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
    J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan.
    Hitani A; Nakamura T; Ohtomo H; Nawa Y; Kimura M
    J Infect Chemother; 2006 Oct; 12(5):277-82. PubMed ID: 17109092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review.
    Andrejko KL; Mayer RC; Kovacs S; Slutsker E; Bartlett E; Tan KR; Gutman JR
    Travel Med Infect Dis; 2019; 27():20-26. PubMed ID: 30654041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice. Malaria prevention in short-term travelers.
    Freedman DO
    N Engl J Med; 2008 Aug; 359(6):603-12. PubMed ID: 18687641
    [No Abstract]   [Full Text] [Related]  

  • 10. Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine.
    Meltzer E; Schwartz E
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30535377
    [No Abstract]   [Full Text] [Related]  

  • 11. WITHDRAWN: Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2015 Oct; (10):CD006491. PubMed ID: 26436859
    [No Abstract]   [Full Text] [Related]  

  • 12. Malaria: treatment.
    Winstanley P
    J R Coll Physicians Lond; 1998; 32(3):203-7. PubMed ID: 9670144
    [No Abstract]   [Full Text] [Related]  

  • 13. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
    Senn N; D'Acremont V; Landry P; Genton B
    Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mefloquine has more adverse effects than other drugs for malaria prophylaxis.
    Eaton L
    BMJ; 2009 Oct; 339():b4167. PubMed ID: 19825970
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.
    Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T
    Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283
    [No Abstract]   [Full Text] [Related]  

  • 16. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria.
    Nakato H; Vivancos R; Hunter PR
    J Antimicrob Chemother; 2007 Nov; 60(5):929-36. PubMed ID: 17848375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema multiforme and Malarone(®).
    Becher G; Wylie G
    Travel Med Infect Dis; 2012 Sep; 10(5-6):279-80. PubMed ID: 22951669
    [No Abstract]   [Full Text] [Related]  

  • 18. Atovaquone-proguanil use in early pregnancy and the risk of birth defects.
    Pasternak B; Hviid A
    Arch Intern Med; 2011 Feb; 171(3):259-60. PubMed ID: 21325117
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence to malaria prophylaxis among Peace Corps Volunteers in the Africa region, 2013.
    Landman KZ; Tan KR; Arguin PM
    Travel Med Infect Dis; 2015; 13(1):61-8. PubMed ID: 25534297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.